Therapeutic strategy in patients with non-small cell lung cancer associated to satellite pulmonary nodules

被引:14
|
作者
Carretta, A
Ciriaco, P
Canneto, B
Nicoletti, R
Del Maschio, A
Zannini, P
机构
[1] Vita Salute San Raffaele Univ, San Raffaele Sci Inst, Dept Thorac Surg, I-20132 Milan, Italy
[2] Vita Salute San Raffaele Univ, San Raffaele Sci Inst, Dept Radiol, I-20132 Milan, Italy
关键词
computed tomography scan; non-small cell lung cancer; satellite nodules; diagnosis; surgery;
D O I
10.1016/S1010-7940(02)00108-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: In patients with non-small cell lung cancer (NSCLC) the presence of satellite metastatic nodules may he considered a contraindication to surgical treatment. The use of spiral computed tomography (CT) scan has improved the accuracy of the diagnostic assessment of pulmonary diseases. but has also led to the detection of a consistent number of indeterminate satellite lesions. Obtaining a differential diagnosis of these lesions is extremely important in defining the therapeutic strategy. The aim of the study was, to assess the characteristics of satellite nodules in patients with NSCLC and to examine the diagnostic and therapeutic approach used in the presence of indeterminate satellite lesions. Methods: From November 1995 to February, 2001, 29 patients (mean age 64 years) who underwent surgery for NSCLC had indeterminate satellite pulmonary lesions at the preoperative spiral CT scan A differential diagnosis of the nodules was obtained by histological examination in 27 patients and by follow-up (62 and 64 months respectively) in two patients. Positron emission tomography (PET) scan was selectively performed in the preoperative evaluation. Results: Thirty-two satellite nodules were analyzed in the group of 29 patients. The size of the lesions varied from 2 to 15 mm (mean 8 mm). The nodules were ipsilateral to the primary tumor in 25 patients and contralateral in four. They were benign in 22 cases and malignant in ten (metastases from NSCLC in seven patients and second primary lung cancer in three). Nodules with a size equal to or less than 5 mm were more frequently benign. Patients with stage III tumors had a higher incidence of malignant satellite nodules in comparison to earlier stages. although the data did not reach statistical significance, PET scat, correctly differentiated benign and malignant satellite nodules in six patients. Conclusions: Obtaining a differential diagnosis of indeterminate pulmonary nodules associated to NSCLC is of great importance in defining the therapeutic strategy. The results of this study show that indeterminate satellite lesions may be benign or represent a second primary lung cancer, and should not therefore be considered a contraindication to surgical exploration when a preliminary differential diagnosis by other means cannot he obtained. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1100 / 1104
页数:5
相关论文
共 50 条
  • [1] Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
    Yano, Tokujiro
    Okamoto, Tatsuro
    Fukuyama, Seiichi
    Maehara, Yoshihiko
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (05): : 1048 - 1054
  • [2] MANAGEMENT OF PATIENTS WITH ANOTHER PULMONARY NODULES OTHERWISE OPERABLE NON-SMALL CELL LUNG CANCER
    Jheon, Sanghoon
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S255 - S256
  • [3] Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer
    Berhoune, Malik
    Banu, Eugeniu
    Scotte, Florian
    Prognon, Patrice
    Oudard, Stephane
    Bonan, Brigitte
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (11) : 1640 - 1652
  • [4] Prognosis in Patients with Non-Small Cell Lung Cancer and Satellite Tumors
    Kocaturk, C. I.
    Gunluoglu, M. Z.
    Cansever, L.
    Dincer, I. S.
    Bedirhan, M. A.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (06): : 360 - 363
  • [5] Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
    Hall, Richard D.
    Le, Tri M.
    Haggstrom, Daniel E.
    Gentzler, Ryan D.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 515 - 523
  • [6] Adjuvant or neoadjuvant therapeutic strategy for resectable non-small cell lung cancer
    Hayashi, Ryuji
    [J]. RESPIRATORY INVESTIGATION, 2023, 61 (02) : 133 - 134
  • [7] Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer
    Ma, Kui
    Tang, Ya H.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (02) : 256 - 264
  • [8] Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy
    Rijavec, Erika
    Genova, Carlo
    Barletta, Giulia
    Burrafato, Giovanni
    Biello, Federica
    Dal Bello, Maria Giovanna
    Coco, Simona
    Truini, Anna
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (07) : 1007 - 1017
  • [9] Therapeutic vaccines in non-small cell lung cancer
    Socola, Francisco
    Scherfenberg, Naomi
    Raez, Luis E.
    [J]. IMMUNOTARGETS AND THERAPY, 2013, 2 : 115 - 124
  • [10] Therapeutic advances in non-small cell lung cancer
    Vallieres, Eric
    Peters, Solange
    Van Houtte, Paul
    Dalal, Paras
    Lim, Eric
    [J]. THORAX, 2012, 67 (12) : 1097 - 1101